Patient and provider perspectives on shared decision making: a systematic review of the peer-reviewed literature [0.03%]
共决策的患者及医生视角：回顾同行评议文献中的相关研究
Nyna Williams,Chris Fleming,Annie Doubleday
Nyna Williams
For comparative effectiveness research to be effective, patients and providers must collaborate in shared decision making (SDM) to make evidence-based clinical decisions that align with patient preferences. We conducted a systematic review ...
Treatment patterns of biologics in US patients with ankylosing spondylitis: descriptive analyses from a claims database [0.03%]
美国强直性脊柱炎患者的生物制剂治疗模式：来自索赔数据库的描述性分析
Jessica A Walsh,Oluwakayode Adejoro,Benjamin Chastek et al.
Jessica A Walsh et al.
Aim: Examine treatment patterns among patients with active ankylosing spondylitis (AS) treated with a TNF inhibitor (TNFi). Patients & methods: ...
Gene therapy: evidence, value and affordability in the US health care system [0.03%]
基因治疗：美国医疗体系中的证据、价值与可负担性
Grace Hampson,Adrian Towse,Steven D Pearson et al.
Grace Hampson et al.
Aims: To explore the challenges presented by gene therapies, discuss potential solutions, and present policy recommendations. Methods: ...
Development and preliminary evidence of the psychometric properties of the GNE myopathy functional activity scale [0.03%]
WAGR综合征儿童的功能活动能力评估量表的编制及初步检验系数
Jill Mayhew,Nicola Bonner,Rob Arbuckle et al.
Jill Mayhew et al.
Aim: GNE myopathy, a rare, severe, progressive myopathy, presents with lower extremity distal muscle weakness. The GNE myopathy functional activity scale (GNEM-FAS) evaluates the impact of GNE myopathy on functioning in a...
Incidence and costs of cardiac device infections: retrospective analysis using German health claims data [0.03%]
德国健康保险数据的心脏设备感染的发病率和成本回顾分析
Saskia Ludwig,Cathrin Theis,Ben Brown et al.
Saskia Ludwig et al.
Aim: Estimate incidence and costs of cardiac device infections (CDIs) in Germany. Materials & methods: Patients had an implantable card...
Qualitative interviews to identify burden of illness, impacts and costs associated with surgical site infections [0.03%]
定性访谈识别手术部位感染的疾病负担、影响和成本
Heather L Gelhorn,Savita B Anand,Javad Parvizi et al.
Heather L Gelhorn et al.
Aim: To gather qualitative data from patients on the burden, impacts and costs of surgical site infections (SSI) requiring second surgeries. Patients & me...
Iso-osmolar contrast media and adverse renal and cardiac events after percutaneous cardiovascular intervention [0.03%]
等渗对比剂与冠脉介入治疗后肾功能和心脏不良事件的关系
Peter A McCullough,Guy David,Thomas M Todoran et al.
Peter A McCullough et al.
Aim: To assess the relationship between type of contrast media (CM), iso-osmolar contrast media (IOCM) or low-osmolar contrast media (LOCM), and major adverse renal and cardiovascular events (MARCE). ...
An indirect comparison of ustekinumab and vedolizumab in the therapy of TNF-failure Crohn's disease patients [0.03%]
乌司奴单抗与维多珠单抗治疗TNF抑制剂失效的克罗恩病患者的间接比较研究
Paweł Kawalec,Paweł Moćko
Paweł Kawalec
Aim: An indirect comparison of ustekinumab versus vedolizumab in patients with active moderate-to-severe Crohn's disease who were nonresponsive or intolerant to previous TNF-antagonist therapy. ...
Ticagrelor versus clopidogrel in East-Asian patients with acute coronary syndromes: a meta-analysis of randomized trials [0.03%]
替卡格雷与氯吡格雷治疗东亚急性冠脉综合征患者的有效性及安全性的随机对照临床试验的Meta分析
Bin Wu,Houwen Lin,Ruoyan Gai Tobe et al.
Bin Wu et al.
Aim: To determine whether ticagrelor or clopidogrel provides the best outcomes for East-Asian patients with acute coronary syndrome (ACS). Materials & met...
Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1 [0.03%]
利用CHAC1基因mRNA表达开发乳腺癌患者的新型预后评分系统
Beate Jahn,Marjan Arvandi,Ursula Rochau et al.
Beate Jahn et al.
Aim: To develop a prognostic score for primary breast cancer patients integrating conventional predictors and the novel biomarker CHAC1 to aid adjuvant chemotherapy decisions. ...